Literature DB >> 7558276

Immunogenicity of synthetic peptides of Haemophilus influenzae type b outer membrane protein P1.

P Chong1, Y P Yang, D Persaud, M Haer, B Tripet, E Tam, C Sia, M Klein.   

Abstract

To identify the B- and T-cell epitopes of P1 of Haemophilus influenzae type b, 13 peptides covering 90% of the protein were chemically synthesized. Mouse, guinea pig, and rabbit antisera raised against purified native P1 were tested for their reactivities against the peptides in peptide-specific enzyme-linked immunosorbent assays (ELISAs). Six immunodominant linear B-cell epitopes were mapped to residues 103 to 137, 189 to 218, 248 to 283, 307 to 331, 384 to 412, and 400 to 437 of the mature P1 protein. When P1 peptides were screened for their reactivities with three human convalescent-phase serum specimens, peptides corresponding to residues 39 to 64, 226 to 253, and 400 to 437 reacted strongly with the antisera. Four regions (residues 39 to 64, 226 to 253, 339 to 370, and 400 to 437) contained murine T-cell epitopes. Rabbit antipeptide antisera were tested for their reactivities with the immunizing peptides and P1 protein by ELISA and immunoblots. All anti-P1 peptide antisera except those raised against peptide HIBP1-8 (residues 279 to 312) or HIBP1-8-keyhole limpet hemocyanin conjugate were shown to be specific for their respective immunizing peptides by ELISA. In addition, rabbit antisera raised against the synthetic peptides corresponding to residues 1 to 29, 39 to 64, 103 to 137, 189 to 218, 226 to 253, 248 to 283, 307 to 331, and 400 to 437 of the mature P1 protein recognized the P1 protein from both typeable and nontypeable isolates. These results suggest that these peptides contain epitopes highly conserved among typeable and nontypeable strains of H. influenzae. However, none of the antipeptide antisera have bactericidal activity, nor were they protective against H. influenzae type b in the infant rat model of bacteremia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558276      PMCID: PMC173527          DOI: 10.1128/iai.63.10.3751-3758.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  30 in total

1.  Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs.

Authors:  P Preston-Hurlburt; B K al-Ramadi; J Rothbard; C A Janeway
Journal:  Nature       Date:  1992-10-01       Impact factor: 49.962

2.  A new phosphorylated intermediate in glucose oxidation.

Authors:  J MACGEE; M DOUDOROFF
Journal:  J Biol Chem       Date:  1954-10       Impact factor: 5.157

3.  Structural and functional analysis of the S1 subunit of pertussis toxin using synthetic peptides.

Authors:  P Chong; M Sydor; E Wu; G Zobrist; H Boux; M Klein
Journal:  Mol Immunol       Date:  1991-03       Impact factor: 4.407

Review 4.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

5.  Identification of a surface-exposed immunodominant epitope on outer membrane protein P1 of Haemophilus influenzae type b.

Authors:  C Proulx; R S Munson; S Grass; J Hamel; D Martin; B R Brodeur
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

6.  Identification of surface-exposed B-cell epitopes recognized by Haemophilus influenzae type b P1-specific monoclonal antibodies.

Authors:  H Panezutti; O James; E J Hansen; Y Choi; R E Harkness; M H Klein; P Chong
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  Immunoprotection of rats against Haemophilus influenzae type B disease mediated by monoclonal antibody against a haemophilus outer-membrane protein.

Authors:  E J Hansen; S M Robertson; P A Gulig; C F Frisch; E J Haanes
Journal:  Lancet       Date:  1982-02-13       Impact factor: 79.321

8.  Identification of T- and B-cell epitopes of the S2 and S3 subunits of pertussis toxin by use of synthetic peptides.

Authors:  P Chong; G Zobrist; C Sia; S Loosmore; M Klein
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

9.  Molecular analysis of the P2 porin protein of nontypeable Haemophilus influenzae.

Authors:  D J Sikkema; T F Murphy
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

10.  Immunogenicity of overlapping synthetic peptides covering the entire sequence of Haemophilus influenzae type b outer membrane protein P2.

Authors:  P Chong; Y P Yang; R Fahim; P McVerry; C Sia; M Klein
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

View more
  8 in total

1.  Identification of a cross-reactive continuous B-cell epitope in enterotoxigenic Escherichia coli colonization factor antigen I.

Authors:  A Rudin; A M Svennerholm
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

2.  Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach.

Authors:  G R Bolduc; V Bouchet; R Z Jiang; J Geisselsoder; Q C Truong-Bolduc; P A Rice; S I Pelton; R Goldstein
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

3.  Analysis of the Yersinia pestis V protein for the presence of linear antibody epitopes.

Authors:  J K Pullen; G W Anderson; S L Welkos; A M Friedlander
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

4.  DNA sequence analysis and restriction fragment length polymorphisms of the P1 gene of Haemophilus influenzae biogroup aegyptius associated with Brazilian purpuric fever.

Authors:  R B Reed; J B Frost; K Kort; S D Myers; A J Lesse
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

5.  A strategy for rational design of fully synthetic glycopeptide conjugate vaccines.

Authors:  P Chong; N Chan; A Kandil; B Tripet; O James; Y P Yang; S P Shi; M Klein
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

6.  Nontypeable Haemophilus influenzae: pathogenesis and prevention.

Authors:  A R Foxwell; J M Kyd; A W Cripps
Journal:  Microbiol Mol Biol Rev       Date:  1998-06       Impact factor: 11.056

7.  A 20-kilodalton N-terminal fragment of the D15 protein contains a protective epitope(s) against Haemophilus influenzae type a and type b.

Authors:  Y p Yang; W R Thomas; P Chong; S M Loosmore; M H Klein
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

8.  Positively selected codons in immune-exposed loops of the vaccine candidate OMP-P1 of Haemophilus influenzae.

Authors:  Ted H M Mes; Jos P M van Putten
Journal:  J Mol Evol       Date:  2007-03-19       Impact factor: 2.395

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.